An acute inflammatory response to the use of granulocyte colony- stimulating factor to prevent infections in patients with brain injury: What about the brain?

Critical Care Medicine

Volumn 27, Issue 5, 1999, Pages 1014-1018

  Kochanek, Patrick M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Contusion; Granulocyte colony stimulating factor (G CSF); Head injury; Inflammation; Leukocyte; Neutrophil; Traumatic brain injury

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

BLOOD BRAIN BARRIER; BRAIN CONTUSION; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INJURY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; DRUG SAFETY; ENCEPHALITIS; HOSPITAL INFECTION; HUMAN; MULTICENTER STUDY; NEUTROPHIL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

BRAIN INJURIES; CEREBRAL HEMORRHAGE; CROSS INFECTION; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATION; NEUTROPHILS;

EID: 0032990193     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199905000-00049     Document Type: Review

References (43)

1. 1. Heard SO, Fink MF, Gamelli RL, et al: Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. The Filgrastim Study Group. Crit Care Med 1998; 26:748-754
2. 2. Shohami E, Bass R, Wallach D, et al: Inhibition of tumor necrosis factor alpha (TNFα) activity in rat brain is associated with cerebroprotection after closed head injury. J Cereb Blood Flow Metab 1996; 16:378-384
3. 3. Goss JR, Styren SD, Miller PD, et al: Hypothermia attenuates the normal increase in interleukin 1 beta RNA and nerve growth factor following traumatic brain injury in the rat. J Neurotrauma 1995; 12:159-167
4. 4. Carlos TM, Clark RS, Franicola-Higgins D, et al: Expression of endothelial adhesion molecules and recruitment of neutrophils after traumatic brain injury in rats. J Leukocyte Biol 1997; 61:279-285
5. 5. Whalen MJ, Carlos TM, Clark RSB, et al: The effect of brain temperature on acute inflammation after traumatic brain injury in rats. J Neurotrauma 1997; 14:561-572
6. 6. McClain C, Cohen D, Phillips R, et al: Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J Clin Lab Med 1991; 118:226-231
7. 7. Kossmann T, Hans VHJ, Lenzlinger PM, et al: Analysis of immune mediator production following traumatic brain injury. In: Shock, Sepsis, and Organ Failure: Brain Damage Secondary to Hemorrhagic-Traumatic Shock, Sepsis, and Traumatic Brain Injury. Fifth Wiggers Bernard Conference 1996. Schlag G, Redl H, Traber D (Eds). Berlin, Springer-Verlag, 1997, pp 263-304
8. 8. Kossmann T, Stahel PF, Morganti-Kossmann MC, et al: Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injury. J Neuroimmunol 1997; 73:63-69
9. 9. Kossmann T, Stahel PF, Lenzlinger PM, et al: Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J Cereb Blood Flow Metab 1997; 17:280-289
10. 10. Bell M, Kochanek PM, Doughty LA, et al: Interleukin-6 and interleukin-10 in cerebrospinal fluid after traumatic brain injury in children. J Neurotrauma 1997; 14:451-457
11. 11. Marion DW, Penrod LE, Kelsey SF, et al: Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med 1997; 336:540-546
12. 12. Whalen M, Carlos T, Kochanek P, et al: Soluble adhesion molecules in CSF are increased in children with severe head injury. J Neurotrauma 1998; 15: 777-787
13. 13. Gupta AK, Thiru S, Bradley J, et al: Delayed increases in adhesion molecule expression after traumatic brain injury in humans: Preliminary results. J Cereb Blood Flow Metab 1995; 15:S33
14. 14. Holmin S, Soderlund J, Biberfeld P, et al: Intracerebral inflammation after human brain contusion. Neurosurgery 1998; 42:291-299
15. 15. Adelson PD, Whalen M, Robichaud P, et al: Blood-brain barrier permeability and acute inflammation in two models of traumatic brain injury in the immature rat. In: Proceedings of the 10th International Symposium on Intracranial Pressure and Neuromonitoring in Brain Injury, Williamsburg, VA, Marmarou A, Bullock R, Avezaat C, Baethmann A, Becker D, Brock M, Hoff J, Nagai H, Reulen HJ, Teasdale G (Eds). Springer, Wien, 1997, pp. 104-106
16. 16. Toulmond S, Rothwell NJ: Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res 1995; 671: 261-266
17. 17. Tuomanen E, Saukkonen K, Sande S, et al: Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J Exp Med 1989; 170:959-968
18. 18. Saez-Llorens X, Jafari HS, Severien C, et al: Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis. J Clin Invest 1991; 88:2003-2011
19. 19. Tang T, Frenette PS, Hynes RO, et al: Cytokine-induced meningitis is dramatically attenuated in mice deficient in endothelial selectins. J Clin Invest 1996; 97:2485-2490
20. 20. Weber JR, Angstwurm K, Burger W, et al: Anti ICAM-1 (CD 54) monoclonal antibody reduces inflammatory changes in experimental bacterial meningitis. J Neuroimmunol 1995; 63:63-68
21. 21. Shiga Y, Onodera H, Kogure K, et al: Neutrophil as a mediator of ischemic edema formation in the brain. Neurosci Lett 1991; 125:110-112
22. 22. Matsuo Y, Onodera H, Shiga Y, et al: Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res 1994; 656:344-352
23. 23. LindsbergPJ, Siren AL, Feuerstein GZ, et al: Antagonism of neutrophil adherence in the deteriorating stroke model in rabbits. J Neurosurg 1995; 82: 269-277
24. 24. Zhang RL, Chopp M, Jiang N, et al: Anti-cellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 1995; 26:1438-1443
25. 25. Connelly ES, Winfree CJ, Springer TA, et al: Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion: Role of neutrophil adhesion in the pathogenesis of stroke. J Clin Invest 1996; 97: 209-216
26. 26. Chopp M, Li Y, Jiang N, et al: Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. J Cereb Blood Flow Metab 1996; 16:578-584
27. 27. Schoettle RJ, Kochanek PM, Magargee MJ, et al: Early polymorphonuclear leukocyte accumulation correlates with the development of posttraumatic cerebral edema in rats. J Neurotrauma 1990; 7:207-217
28. 28. Holmin S, Mathiesen T: Biphasic edema development after experimental brain contusion in rat. Neurosci Lett 1995; 194:97-100
29. 29. Uhl MW, Biagas KV, Grundl PD, et al: Effects of neutropenia on edema, histology, and cerebral blood flow after traumatic brain injury in rats. J Neurotrauma 1994; 11:303-315
30. 30. Clark RS, Kochanek PM, Schwarz MA, et al: Inducible nitric oxide synthase expression in cerebrovascular smooth muscle and neutrophils after traumatic brain injury in immature rats. Pediatr Res 1996; 39:784-790
31. 31. Soares HD, Hicks RR, Smith D, et al: Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J Neurosci 1995; 15:8223-8233
32. 32. Whalen MJ, Carlos TM, Kochanek PM, et al: Blood brain barrier permeability, neutrophil accumulation and vascular adhesion molecule expression after controlled cortical impact in rats. In: Tenth International Symposium on Intracranial Pressure and Neuromonitoring in Brain Injury, 1997, Williamsburg, VA
33. 33. Kochanek PM, Hallenbeck JM: Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992; 23:1367-1379
34. 34. Chopp M, Zhang RL, Chen H, et al: Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke 1994; 25:869-875; discussion 875-866
35. 35. Matsuo Y, Kihara T, Ikeda M, et al: Role of neutrophils in radical production during ischemia and reperfusion of the rat brain: effect of neutrophil depletion on extracellular ascorbyl radical formation. J Cereb Blood Flow Metab 1995; 15:941-947
36. 36. Adelson PD, Clyde B, Kochanek PM, et al: Cerebrovascular response in infants and young children following severe traumatic brain injury: A preliminary report. Pediatr Neurosurg 1997; 26: 200-207
37. 37. Soriano SG, Wang YF, Lipton SA, et al: ICAM-1 dependent pathway is not involved in the development of neuronal apoptosis after transient focal cerebral ischemia. Brain Res 1998; 780:337-341
38. 38. Whalen MJ, Carlos TM, Adelson PD, et al: Interleukin-8 is increased in CSF of children with severe traumatic brain injury. Crit Care Med 1998; 26:A85
39. 39. Morganti-Kossman MC, Lenzlinger PM, Hans V, et al: Production of cytokines following brain injury: Beneficial and deleterious for the damaged tissue. Mol Psychiatry 1997; 2:133-136
40. 40. DeKosky ST, Styren SD, O'Malley ME, et al: Interleukin-1 receptor antagonist suppresses neurotrophin response in injured rat brain. Ann Neurol 1996; 39:123-127
41. 41. Scherbel U, Raghupati R, Nakamura M, et al: Evaluation of the neurobehavioral deficits in brain-injured tumor necrosis factor-deficient mice after experimental brain injury. J Neurotrauma 1997; 14:781
42. 42. Sinz EH, Kochanek PM, Dixon CE, et al: Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. J Neurotrauma In Press
43. 43. Esposito C, Banks SM, Eichacker PQ: Prophylactic granulocyte colony-stimulating factor in critically ill patients: Not time yet. Crit Care Med 1998; 26:636-637